Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Soltermann

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
Pathology, Research and Practice|March 28, 2018
Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective studyNadezda P Velizheva, Markus P Rechsteiner, Nadejda Valtcheva, et al.
Nature Communications|August 24, 2023
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotypeStefanie Hiltbrunner, Lena Cords, Sabrina Kasser, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomyByron K Y Bitanihirwe, Mayura Meerang, Martina Friess, et al.
Cancer Research|December 28, 2017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell CarcinomaKarīna Siliņa, Alex Soltermann, Farkhondeh Movahedian Attar, et al.
Virchows Archiv : an International Journal of Pathology|May 26, 2019
PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation studySpasenija Savic, Sabina Berezowska, Serenella Eppenberger-Castori, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Human Pathology|February 22, 2011
SOX2 amplification is a common event in squamous cell carcinomas of different organ sitesSebastian Maier, Theresia Wilbertz, Martin Braun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Mechanisms of Primary Drug Resistance in <i>FGFR1</i>-Amplified Lung CancerFlorian Malchers, Meryem Ercanoglu, Daniel Schütte, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerTheresia Wilbertz, Patrick Wagner, Karen Petersen, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
Pathology, Research and Practice|March 28, 2018
Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective studyNadezda P Velizheva, Markus P Rechsteiner, Nadejda Valtcheva, et al.
Nature Communications|August 24, 2023
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotypeStefanie Hiltbrunner, Lena Cords, Sabrina Kasser, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomyByron K Y Bitanihirwe, Mayura Meerang, Martina Friess, et al.
Cancer Research|December 28, 2017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell CarcinomaKarīna Siliņa, Alex Soltermann, Farkhondeh Movahedian Attar, et al.
Virchows Archiv : an International Journal of Pathology|May 26, 2019
PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation studySpasenija Savic, Sabina Berezowska, Serenella Eppenberger-Castori, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Human Pathology|February 22, 2011
SOX2 amplification is a common event in squamous cell carcinomas of different organ sitesSebastian Maier, Theresia Wilbertz, Martin Braun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Mechanisms of Primary Drug Resistance in <i>FGFR1</i>-Amplified Lung CancerFlorian Malchers, Meryem Ercanoglu, Daniel Schütte, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerTheresia Wilbertz, Patrick Wagner, Karen Petersen, et al.
Pageof 12